Meet the 10th Annual Meeting Keynote and Invited Speakers:

Ronald Chen

University of Kansas

Dr. Chen is the Brandmeyer Professor and Chair of the Department of Radiation Oncology and Associate Director of Health Equity at the University of Kansas Cancer Center. Dr. Chen is a GU radiation oncologist who has written many national guidelines for ASCO, ASTRO and AUA. His research focuses on comparative effectiveness, disparities, clinical trials, and quality of life, and he has published more than 250 peer-reviewed articles.Dr. Chen earned a Bachelor's degree from the University of Kansas, an MD from Harvard Medical School and a Master of Public Health degree from Harvard School of Public Health. He completed his residency and served as chief resident at the Harvard Radiation Oncology Program.

J. Isabelle Choi

New York Proton Centre

Dr. Isabelle Choi is the Clinical Director and Director of Research at the New York Proton Center and lead of the Breast Cancer and Gastrointestinal Cancer Services at NYPC.  Her research focus is in improving outcomes, reducing toxicities, and improving radiotherapy treatment delivery for breast, gastrointestinal, and thoracic malignancies.  She is also an Assistant Member of Radiation Oncology at Memorial Sloan Kettering Cancer Center, where she is a member of the breast service. Among her select national leadership appointments, Dr. Choi is Chair of the Physician Advisory Committee of the National Association for Proton Therapy, Chair of the ARS AUC Breast Committee, Chair of the Proton Collaborative Group (PCG) Breast Committee, and Chair of the PCG Publications Committee.

Stella Flampouri

Emory University

Stella Flampouri joined the Emory University Department of Radiation Oncology faculty and the medical physics team at Emory Proton Therapy Center in 2019. Before that, she received her PhD in Medical Physics from the Institute of Cancer Research in the UK, completed her post-doctoral fellowship at MGH, and was faculty at the University of Florida Proton Therapy Institute. Stella's research interests include the evaluation of proton radiation dose uncertainties and investigating techniques to mitigate the effects.  She has been working on lung and lymphoma proton treatment planning and delivery methodologies and is involved in multiple multi-institutional clinical trials.

Steven Frank

The UT MD Anderson Cancer Center

Steven J. Frank, MD, is an endowed tenured professor of Radiation Oncology and holds the Bessie McGoldrick Professorship in Clinical Research at The University of Texas MD Anderson Cancer Center.  Dr. Frank is the Executive Director of the Particle Therapy Institute and Deputy Head of Strategy for the Division of Radiation Oncology.  Dr. Frank’s lab is studying the biologic enhancement factor of proton therapy and FLASH radiotherapy for head and neck cancer, as well as MRI-Assisted Radiosurgery (MARS) as the next generation of prostate brachytherapy. Dr. Frank has approximately 300 peer-reviewed publications, has authored many book chapters, and has recently published the first textbook on Proton Therapy based on the MD Anderson experience. 

Matthew Hall

Miami Cancer Institute, Baptist Health South Florida

Matthew Hall, MD, MBA is the lead pediatric radiation oncologist and chief of the sarcoma and skull base radiation oncology services at Miami Cancer Institute, Baptist Health South Florida.

Rafi Kabarriti

Montefiore Medical Center

Biography coming soon ...

Bridget Koontz

East Carolina University

Dr. Koontz trained at Harvard Medical School, University of North Carolina-Chapel Hill, and Duke University School of Medicine. In 2007 on completion of training she joined as faculty in the Department of Radiation Oncology, earning tenure as an Associate Professor and serving in several leadership roles. From 2021 to 2023, she was the US Chief Medical Officer for GenesisCare, a global oncology network and research organization. She now leads Radiation Oncology services at the AdventHealth Cancer Institute in Orlando Florida. Her interests are in promoting excellence of clinical care for patients with genitourinary malignancies and developing clinical and translational research to improve both the treatment of and recovery from cancer.

Nancy Lee

Memorial Sloan Kettering Cancer Center

Biography coming soon ...

Haibo Lin

New York Proton Center

Biography coming soon ...

Charles Mayo

University of Michigan

I did my doctoral work at the University of Massachusetts at Amherst where I developed an optical technique to investigate antibody - adsorption kinetics using surface plasmon resonance as a probe. My post-doctoral work was in proton radiation therapy at the Harvard Cyclotron Laboratory where I focused on particle beam line calibration including discovery of edge scattering effects. My primary research interest centers on constructing standardized large scale data bases from routine practice data for use in integrating artificial intelligence driven modeling into clinical care. As Director of Informatics and Analytics in the Department of Radiation Oncology I led our team in creation of our platform, named the Michigan Radiation Oncology Analytics Resource System (MROAR), that aggregates, integrates and harmonizes data from the several commercial data systems used to treat radiation oncology patients into a single, easy to use platform.

Radhe Mohan - Keynote Speaker

MD Anderson

Dr. Radhe Mohan, PhD, FAAPM, FASTRO, is a professor and the holder of the Larry and Pat McNeil Chair in the Department of Radiation Physics at MD Anderson Cancer Center.    Dr. Mohan’s extensive experience includes pioneering contributions in wide array of areas of radia-tion physics and oncology.  Since 2005, his research has been focused on various physical, clini-cal, biological aspects of proton therapy and, more recently, on immunomodulatory effects of proton therapy.  He has over 450 in peer-reviewed publication.  He was the Senior Physics Edi-tor of The International Journal of Radiation Oncology, Biology, and Physics from 2002 through 2011.  Dr. Mohan has been the Co-Principal Investigator three 5-year National Cancer Insti-tute’s Program Project grants on proton therapy.   Additionally, he has been awarded numerous research grants by the NCI and industry.

Harald Paganetti - Keynote Speaker

Massachusetts General Hospital

Harald Paganetti is a Professor of Radiation Oncology at Harvard Medical School and Director of Physics Research Harald Paganetti is a Professor of Radiation Oncology at Harvard Medical School and Director of Physics Research for the Department of Radiation Oncology at Massachusetts General Hospital. He received his PhD in experimental nuclear physics in 1992 from the Rheinische-Friedrich-Wilhelms University in Bonn, Germany. He has been working in radiation therapy research since 1994 and has made many significant contributions to the field of radiation oncology physics and biology, specifically in proton therapy. He has published close to 300 peer-reviewed articles and has an h-index of 81 on google scholar. He has also edited 3 books on proton radiation therapy. His research interests include planning and delivery uncertainties in radiation therapy, biological effect modeling, Monte Carlo dose calculation, advanced optimization and imaging techniques as well as understanding radiation induced toxicities and systemic effects on the immune system. His work has been funded mostly by the National Institute of Health, including 7 R01 grant awards as Principal Investigator throughout his career. In 2022 he received the PTCOG Robert R. Wilson Award for significant contributions to the field of particle therapy.

Stephanie Perkins

Washington University School of Medicine

Dr. Stephanie Perkins is the S. Lee Kling Endowed Chair of Radiation Oncology at Washington University School of Medicine.  She serves as the Director of the S. Lee Kling Proton Therapy Center and Chief of the Pediatric Radiotherapy Service.  Dr. Perkins attended medical school at the University of Tennessee, Memphis and completed her residency training at Washington University.  She specializes in the treatment of pediatric cancers with a focus on proton therapy.  She also cares for adult patients with sarcomas, brain tumors and brain metastases, including expertise in Gamma Knife radiosurgery.  Her research interests are focused on the late effects of therapy in childhood survivors of brain tumors.

Nicholas Remmes

Mayo Clinic

Nicholas Remmes, PhD, DABR has been practicing proton therapy at Mayo Clinic (Rochester, MN) since Mayo Clinic first started treating with proton therapy in 2015.  He is currently the program director of the Mayo Clinic Clinical Medical Physics Residency Program in Radiation Oncology, the Mayo Clinic Proton Medical Physics Fellowship Program, and the Mayo Clinic Proton Medical Physics Professional Enhancement Program.  He is the physics co-chair for the RADCOMP Pragmatic Randomized Clinical Trial of Proton vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer.  Dr. Remmes’s interests include the use of proton therapy in breast cancer, shielding and radiation safety in proton therapy, the practical application of LET enhancement and biological models in proton and heavier ion therapy, the use of proton therapy in patients with implanted electronic devices, and the use of proton therapy for pregnant patients.

Charles B. Simonne

New York Proton Center

Charles B. Simone, II, MD, FACRO is Research Professor and Chief Medical Officer of the New York Proton Center. He is also a Full Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert in proton therapy to treat thoracic malignancies and reirradiation, and in developing innovative clinical trial strategies in thoracic oncology.  He was previously Chief of the Thoracic Oncology Service, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in Radiation Oncology at University of Pennsylvania.  He then became Medical Director of Maryland Proton Treatment Center.  At Maryland, he was also Chair of the Clinical Research Committee for their Comprehensive Cancer Center, proton therapy Fellowship Director, and Director of Stereotactic Radiation Therapy. He completed his undergraduate and medical training at UPenn and radiation oncology residency at NCI/NIH, where he was chief resident.

Nancy Tarbell - Keynote Speaker

Massachusetts General Hospital

Biography coming soon ...

Phuoc Tran

University of Maryland

Phuoc T. Tran, MD, PhD, is Professor and Vice Chair for Research of Radiation Oncology at the University of Maryland. Phuoc received his MD-PhD from OHSU, completed radiation oncology residency and postdoctoral fellowship at Stanford. Phuoc’s training focused on DNA repair, cancer biology, and transgenic mouse models.  Phuoc is a board-certified radiation oncologist and clinically specializes in treatment of GU malignancies.  His laboratory research funded by the NIH, DoD and foundations focuses on tumor cell epithelial plasticity programs, novel agents to enhance the local and systemic effects of radiation and the oligometastatic state, all to improve the outcomes of patients with cancer. 

Suzanne Wolden

Memorial Sloan Kettering Cancer Center

Biography coming soon ...

Josh Yamada

Memorial Sloan Kettering Cancer Center

Biography coming soon ...

PTCOG-NA Copyright © 2019. All Rights Reserved.
Powered by APPTIDE | Terms of Service